Quarterly report pursuant to Section 13 or 15(d)

3. Significant Strategic Drug Development Collaborations (Details Narrative)

v3.8.0.1
3. Significant Strategic Drug Development Collaborations (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Collaborative Agreements [Member]    
Research and Development Arrangement, Contract to Perform for Others [Line Items]    
Income from collaborative agreements $ 0 $ 0